Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne S R van Lindert

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Atherosclerosis|September 22, 2007
Quantification of epicardial and peri-coronary fat using cardiac computed tomography; reproducibility and relation with obesity and metabolic syndrome in patients suspected of coronary artery diseasePetra M Gorter, Anne S R van Lindert, Alexander M de Vos, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 21, 2018
[National variation in molecular diagnostics in metastatic lung cancer]Chantal C H J Kuijpers, Michel M van den Heuvel, Lucy I H Overbeek, et al.
Acta Oncologica (Stockholm, Sweden)|March 17, 2023
Feasibility and first results of the 'Trials-within-Cohorts' (TwiCs) design in patients undergoing radiotherapy for lung cancerMathijs L Tomassen, Pim J J Damen, Helena M Verkooijen, et al.
Annals of Surgical Oncology|October 31, 2021
Non-Small-Cell Lung Cancer Patients with a High Predicted Risk of Irradical Resection: Can Chemoradiotherapy Offer Similar Survival?W Hugo van Joolingen, Marnix J A Rasing, Max Peters, et al.
Infectious Diseases (London, England)|December 28, 2016
Positive predictive value of ELISpot in BAL and pleural fluid from patients with suspected pulmonary tuberculosisRegina W Hofland, Steven F T Thijsen, Anne S R van Lindert, et al.
Genes|January 21, 2023
Association between Genetic Variants and Peripheral Neuropathy in Patients with NSCLC Treated with First-Line Platinum-Based TherapyCorine de Jong, Gerarda J M Herder, Simone W A van Haarlem, et al.
Scientific Reports|April 8, 2022
Individual treatment effect estimation in the presence of unobserved confounding using proxies: a cohort study in stage III non-small cell lung cancerWouter A C van Amsterdam, Joost J C Verhoeff, Netanja I Harlianto, et al.
JCO Precision Oncology|October 11, 2021
Clinical Utility of Plasma-Based Comprehensive Molecular Profiling in Advanced Non-Small-Cell Lung CancerRobert D Schouten, Daan C L Vessies, Linda J W Bosch, et al.
Cancer Immunology, Immunotherapy : CII|June 12, 2022
Hematologic malignancies following immune checkpoint inhibition for solid tumorsMick J M van Eijs, Lotte E van der Wagen, Rogier Mous, et al.
Current Problems in Cancer|August 30, 2021
Adjuvant Treatment Following Irradical Resection of Stage I-III Non-small Cell Lung Cancer: A Population-based StudyMarnix J A Rasing, Max Peters, Mieke J Aarts, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Atherosclerosis|September 22, 2007
Quantification of epicardial and peri-coronary fat using cardiac computed tomography; reproducibility and relation with obesity and metabolic syndrome in patients suspected of coronary artery diseasePetra M Gorter, Anne S R van Lindert, Alexander M de Vos, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 21, 2018
[National variation in molecular diagnostics in metastatic lung cancer]Chantal C H J Kuijpers, Michel M van den Heuvel, Lucy I H Overbeek, et al.
Acta Oncologica (Stockholm, Sweden)|March 17, 2023
Feasibility and first results of the 'Trials-within-Cohorts' (TwiCs) design in patients undergoing radiotherapy for lung cancerMathijs L Tomassen, Pim J J Damen, Helena M Verkooijen, et al.
Annals of Surgical Oncology|October 31, 2021
Non-Small-Cell Lung Cancer Patients with a High Predicted Risk of Irradical Resection: Can Chemoradiotherapy Offer Similar Survival?W Hugo van Joolingen, Marnix J A Rasing, Max Peters, et al.
Infectious Diseases (London, England)|December 28, 2016
Positive predictive value of ELISpot in BAL and pleural fluid from patients with suspected pulmonary tuberculosisRegina W Hofland, Steven F T Thijsen, Anne S R van Lindert, et al.
Genes|January 21, 2023
Association between Genetic Variants and Peripheral Neuropathy in Patients with NSCLC Treated with First-Line Platinum-Based TherapyCorine de Jong, Gerarda J M Herder, Simone W A van Haarlem, et al.
Scientific Reports|April 8, 2022
Individual treatment effect estimation in the presence of unobserved confounding using proxies: a cohort study in stage III non-small cell lung cancerWouter A C van Amsterdam, Joost J C Verhoeff, Netanja I Harlianto, et al.
JCO Precision Oncology|October 11, 2021
Clinical Utility of Plasma-Based Comprehensive Molecular Profiling in Advanced Non-Small-Cell Lung CancerRobert D Schouten, Daan C L Vessies, Linda J W Bosch, et al.
Cancer Immunology, Immunotherapy : CII|June 12, 2022
Hematologic malignancies following immune checkpoint inhibition for solid tumorsMick J M van Eijs, Lotte E van der Wagen, Rogier Mous, et al.
Current Problems in Cancer|August 30, 2021
Adjuvant Treatment Following Irradical Resection of Stage I-III Non-small Cell Lung Cancer: A Population-based StudyMarnix J A Rasing, Max Peters, Mieke J Aarts, et al.
Pageof 3